Beijing Tong Ren Tang Chinese Medicine Company Limited EBITDA for the year ending December 31, 2024: USD 92.95 M

Beijing Tong Ren Tang Chinese Medicine Company Limited EBITDA is USD 92.95 M for the year ending December 31, 2024, a -6.87% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Beijing Tong Ren Tang Chinese Medicine Company Limited EBITDA for the year ending December 31, 2023 was USD 99.80 M, a -14.10% change year over year.
  • Beijing Tong Ren Tang Chinese Medicine Company Limited EBITDA for the year ending December 31, 2022 was USD 116.19 M, a 6.25% change year over year.
  • Beijing Tong Ren Tang Chinese Medicine Company Limited EBITDA for the year ending December 31, 2021 was USD 109.36 M, a 10.26% change year over year.
  • Beijing Tong Ren Tang Chinese Medicine Company Limited EBITDA for the year ending December 31, 2020 was USD 99.18 M, a -0.22% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)